Tullis Health Investors
A specialized, commercial-stage healthcare investment manager that provides growth capital and active portfolio support to commercial-stage healthcare companies. Focus areas include medical devices, healthcare services and technology, specialty pharmaceuticals, and biotechnology. The firm emphasizes deal sourcing, clinical and regulatory expertise, board-level engagement, and commercialization support to scale companies.
Tullis Health Investors
Services
Growth capital investment
Providing equity and growth capital to commercial-stage healthcare companies to fund expansion, product launches, and scaling.
Board and strategic advisory
Board-level participation and strategic guidance to portfolio company management teams on go-to-market, clinical strategy and operations.
Deal sourcing and screening
Proprietary deal sourcing, long-horizon screening and diligence processes to identify differentiated healthcare technologies.
Commercialization and go-to-market support
Support for commercialization activities including sales organization development, distribution strategy, and market adoption planning.
Financing and capital markets assistance
Assistance with public offerings, private financings, and credit facility arrangements for portfolio companies.
Regulatory and clinical launch support
Advisory support for regulatory submissions, clinical validation planning, and commercial launch coordination for medical devices and clinical technologies.
Growth capital investment
Providing equity and growth capital to commercial-stage healthcare companies to fund expansion, product launches, and scaling.
Board and strategic advisory
Board-level participation and strategic guidance to portfolio company management teams on go-to-market, clinical strategy and operations.
Deal sourcing and screening
Proprietary deal sourcing, long-horizon screening and diligence processes to identify differentiated healthcare technologies.
Commercialization and go-to-market support
Support for commercialization activities including sales organization development, distribution strategy, and market adoption planning.
Financing and capital markets assistance
Assistance with public offerings, private financings, and credit facility arrangements for portfolio companies.
Regulatory and clinical launch support
Advisory support for regulatory submissions, clinical validation planning, and commercial launch coordination for medical devices and clinical technologies.
Expertise Areas
- Healthcare growth equity
- Commercial-stage investing
- Medical device and biotech sector specialization
- Portfolio commercialization and sales transformation
Key Technologies
- Automated intraoperative neuromonitoring (EMG and SSEP)
- Porous titanium implant materials and porous implant manufacturing
- Surgical access systems, retractors and patient positioners
- Intraoperative navigation and robotic integration